20/20 Biolabs, Inc. (AIDX)
NASDAQ · Healthcare
20/20 Biolabs, Inc. Revenue 2024–2025
20/20 Biolabs, Inc. annual/quarterly revenue history and growth rate from 2024 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- 20/20 Biolabs, Inc. revenue for the quarter ending March 31, 2026 was 353375, a 36.19% decrease year-over-year.
- 20/20 Biolabs, Inc. annual revenue for 2025 was 2.0 M, a 16.71% increase from 2024.
- 20/20 Biolabs, Inc. annual revenue for 2024 was 1.8 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
20/20 Biolabs, Inc. Market Cap — FAQ
20/20 Biolabs, Inc. (AIDX) market cap over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AIDX's market cap history?
The chart and table above show 20/20 Biolabs, Inc.'s market cap by year and by quarter, including the growth rate.